Pitavastatin Impurity 29 | CAS 868536-53-2 - Request Quote
Pitavastatin Impurity 29
| SZ CAT No: | SZ-P023072 |
| CAS No | 868536-53-2 |
| Mol.F. | C20H17NO2 |
| Mol.Wt. | 303.4 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Pitavastatin Impurity 29 is chemically Methyl 2-cyclopropyl-4-phenylquinoline-3-carboxylate. Pitavastatin Impurity 29 is supplied with detailed characterization data compliant with regulatory guideline. Pitavastatin Impurity 29 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pitavastatin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 868536-53-2
Purchase 868536-53-2
Order 868536-53-2
Enquire 868536-53-2
price of 868536-53-2
868536-53-2 Supplier
868536-53-2 Manufacturer
868536-53-2 Exporter
buy high quality Pitavastatin Impurity 29
Purchase Pitavastatin Impurity 29
Pitavastatin Impurity 29 suppliers
Pitavastatin Impurity 29 manufacturers
Pitavastatin Impurity 29 price
Order Pitavastatin Impurity 29
Enquire Pitavastatin Impurity 29
Pitavastatin Impurity 29 cost
Pitavastatin Impurity 29 Supplier
Pitavastatin Impurity 29 Distributor
Pitavastatin Impurity 29 for Method Validation
Pitavastatin Reference Standard
Pitavastatin Impurity 29 for ANDA Filing
Pitavastatin Impurity 29 for Forced Degradation Studies
Pitavastatin Impurity 29 Identification Standards
Pitavastatin Impurity 29 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


